Fritextsökning
Innehållstyper
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
One-step cleaning system for use in clean rooms
The Micronswep cleaning system from Berendsen is a single action cleaning system developed for use in clean rooms.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Blir utvecklingschef
Medicinteknikbolaget Pharmacolog anställer ny utvecklingschef.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Piller med nålar gör inte ont
Biologiskt läkemedel i pillerform klarar fas I.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Hallå där Yvonne Mårtensson...
...vd på Cellavision som lanserar företagsbloggen Cellavision News Blast och en app till Iphone, varför då?
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
De förlänger läkemedels livslängd
I samarbete med Affibody har KTH-forskarna Torbjörn Gräslund och Johan Seijsing utvecklat en ny teknik för att förlänga halveringstiden för proteinläkemedel.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Stockholm-Uppsala life science cluster in brief
Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.
BREAKING